Form 38.5(b) - Willis Towers Watson PLC- Amendment
Source: RNS
Amendment - due to the amendment of Equity transactions, the disclosure made on 27 October for dealings on 26 October has been updated. Sections 2(a) and 3(a) have been updated.
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
|
Name of exempt principal trader |
GOLDMAN SACHS & CO. LLC |
|
Company dealt in |
WILLIS TOWERS WATSON PLC |
|
Class of relevant security to which the dealings being disclosed relate (Note1) |
USD 0.000304635 ordinary shares |
|
Date of dealing |
26 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
|
|
Long |
Short |
||
|
|
Number |
(%) |
Number |
(%) |
|
(1) Relevant securities |
537,017.912 |
(0.41) |
304,279.912 |
(0.23) |
|
(2) Derivatives (other than options) |
51,219 |
(0.03) |
373,212 |
(0.28) |
|
(3) Options and agreements to purchase/sell |
0 |
(0.00) |
0 |
(0.00) |
|
Total |
588,236.912 |
(0.45) |
677,491.912 |
(0.52) |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
|
Class of relevant security: |
Long |
Short |
||
|
|
Number |
(%) |
Number |
(%) |
|
(1) Relevant securities |
|
|
|
|
|
(2) Derivatives (other than options) |
|
|
|
|
|
(3) Options and agreements to purchase/sell |
|
|
|
|
|
Total |
|
|
|
|
3. DEALINGS (Note 3)
(a) Purchases and sales
|
Purchase/sale |
Number of relevant securities |
Price per unit (Note 4) |
|
Purchase |
100 |
201.5700 USD |
|
Purchase |
100 |
201.6650 USD |
|
Purchase |
100 |
201.7000 USD |
|
Purchase |
100 |
202.2900 USD |
|
Purchase |
75 |
202.2900 USD |
|
Purchase |
100 |
202.6700 USD |
|
Purchase |
100 |
202.6900 USD |
|
Purchase |
13 |
202.7500 USD |
|
Purchase |
100 |
202.7600 USD |
|
Purchase |
100 |
202.7900 USD |
|
Purchase |
3,718 |
203.2800 USD |
|
Purchase |
3 |
203.2800 USD |
|
Purchase |
107 |
207.7200 USD |
|
Purchase |
99 |
207.7200 USD |
|
Purchase |
45 |
207.7200 USD |
|
Sale |
47 |
201.6600 USD |
|
Sale |
100 |
201.7700 USD |
|
Sale |
100 |
202.0900 USD |
|
Sale |
100 |
202.5500 USD |
|
Sale |
832 |
203.2800 USD |
|
Sale |
380 |
203.2800 USD |
|
Sale |
52 |
203.2800 USD |
|
Sale |
1,554 |
203.2800 USD |
|
Sale |
66 |
206.4600 USD |
|
Sale |
34 |
206.4600 USD |
|
Sale |
100 |
206.4600 USD |
|
Sale |
100 |
206.4900 USD |
|
Sale |
2 |
206.5200 USD |
|
Sale |
3 |
206.5200 USD |
|
Sale |
100 |
206.5600 USD |
|
Sale |
100 |
206.7300 USD |
|
Sale (Loan Adjust) |
138 |
N/A |
(b) Derivatives transactions (other than options transactions)
|
Product name, e.g. CFD |
Nature of transaction (Note 5) |
Number of relevant securities (Note 6) |
Price per unit (Note 4) |
|
SWAP |
Reducing a short position |
505 |
206.5398 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Product name,e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 4) |
|
|
|
|
|
|
|
|
(ii) Exercising
|
Product name,e.g. call option |
Number of securities |
Exercise price per unit (Note 4) |
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 3)
|
Nature of transaction (Note 7) |
Details |
Price per unit (if applicable) (Note 4) |
|
|
|
|
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
|
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
|
NONE |
Is a Supplemental Form 8 attached? (Note 9) YES
|
Date of disclosure |
30 October 2020 |
|
Contact name |
Kashif Rafiq and Papa Lette |
|
Telephone number |
+44(20) 7051 0547 / +44(20) 7774 7442 |
|
Name of offeree/offeror with which connected |
WILLIS TOWERS WATSON PLC |
|
Nature of connection (Note 9) |
Advisor to Offeree |
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
OPEN POSITIONS (Note 1)
|
Product name,e.g. call option |
Written or purchased |
Number of relevant securities to which the option or derivative relates |
Exercise price (Note 2) |
Type, e.g. American, European etc. |
Expiry date |
|
Swap |
Sold |
185 |
0.0000 |
N/A |
23/09/2021 |
|
Swap |
Sold |
273 |
0.0000 |
N/A |
04/01/2021 |
|
Swap |
Sold |
43,330 |
0.0000 |
N/A |
14/04/2021 |
|
Swap |
Sold |
69,482 |
0.0000 |
N/A |
14/04/2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
